These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24180280)

  • 1. Stimulation of DDX3 expression by ginsenoside Rg3 through the Akt/p53 pathway activates the innate immune response via TBK1/IKKε/IRF3 signalling.
    Choi YJ; Kang LJ; Lee SG
    Curr Med Chem; 2014; 21(8):1050-60. PubMed ID: 24180280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
    Yu S; Chen J; Wu M; Chen H; Kato N; Yuan Z
    J Gen Virol; 2010 Aug; 91(Pt 8):2080-2090. PubMed ID: 20375222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDX3 directly facilitates IKKα activation and regulates downstream signalling pathways.
    Fullam A; Gu L; Höhn Y; Schröder M
    Biochem J; 2018 Nov; 475(22):3595-3607. PubMed ID: 30341167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation.
    Schröder M; Baran M; Bowie AG
    EMBO J; 2008 Aug; 27(15):2147-57. PubMed ID: 18636090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human DEAD box helicase 3 couples IκB kinase ε to interferon regulatory factor 3 activation.
    Gu L; Fullam A; Brennan R; Schröder M
    Mol Cell Biol; 2013 May; 33(10):2004-15. PubMed ID: 23478265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential.
    Oshiumi H; Sakai K; Matsumoto M; Seya T
    Eur J Immunol; 2010 Apr; 40(4):940-8. PubMed ID: 20127681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulating DDX3 expression by serotonin 5-HT receptor 7 through phosphorylation of p53 via the AC-PKA-ERK signaling pathway.
    Kang LJ; Nguyen KVA; Eom S; Choi YJ; Nguyen CN; Lee J; Kim C; Lee S; Lee SG; Lee JH
    J Cell Biochem; 2019 Oct; 120(10):18193-18208. PubMed ID: 31172579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction.
    Ning YJ; Feng K; Min YQ; Deng F; Hu Z; Wang H
    J Biol Chem; 2017 Oct; 292(40):16722-16733. PubMed ID: 28848048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
    Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
    J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication.
    Kang LJ; Choi YJ; Lee SG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2612-21. PubMed ID: 24004833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity.
    Qi D; Hu L; Jiao T; Zhang T; Tong X; Ye X
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Conserved Amino Acids within the NSs of Severe Fever with Thrombocytopenia Syndrome Phlebovirus Are Essential for Anti-interferon Activity.
    Moriyama M; Igarashi M; Koshiba T; Irie T; Takada A; Ichinohe T
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.
    Ito M; Masumi A; Mochida K; Kukihara H; Moriishi K; Matsuura Y; Yamaguchi K; Mizuochi T
    J Innate Immun; 2010; 2(6):607-17. PubMed ID: 20714117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1.
    Lee Y; Song B; Park C; Kwon KS
    PLoS One; 2013; 8(5):e63255. PubMed ID: 23675467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol-3-kinase and Akt are required for RIG-I-mediated anti-viral signalling through cross-talk with IPS-1.
    Yeon SH; Song MJ; Kang HR; Lee JY
    Immunology; 2015 Feb; 144(2):312-20. PubMed ID: 25158146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Kinase MAP4K1 Inhibits Cytosolic RNA-Induced Antiviral Signaling by Promoting Proteasomal Degradation of TBK1/IKKε.
    He TS; Huang J; Chen T; Zhang Z; Cai K; Yu J; Xu LG
    Microbiol Spectr; 2021 Dec; 9(3):e0145821. PubMed ID: 34908452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAP kinase p38α regulates type III interferon (IFN-λ1) gene expression in human monocyte-derived dendritic cells in response to RNA stimulation.
    Jiang M; Österlund P; Fagerlund R; Rios DN; Hoffmann A; Poranen MM; Bamford DH; Julkunen I
    J Leukoc Biol; 2015 Feb; 97(2):307-20. PubMed ID: 25473098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DDX19 Inhibits Type I Interferon Production by Disrupting TBK1-IKKε-IRF3 Interactions and Promoting TBK1 and IKKε Degradation.
    Zhang K; Zhang Y; Xue J; Meng Q; Liu H; Bi C; Li C; Hu L; Yu H; Xiong T; Yang Y; Cui S; Bu Z; He X; Li J; Huang L; Weng C
    Cell Rep; 2019 Jan; 26(5):1258-1272.e4. PubMed ID: 30699353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophages.
    Solis M; Romieu-Mourez R; Goubau D; Grandvaux N; Mesplede T; Julkunen I; Nardin A; Salcedo M; Hiscott J
    Eur J Immunol; 2007 Feb; 37(2):528-39. PubMed ID: 17236232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFIT5 Negatively Regulates the Type I IFN Pathway by Disrupting TBK1-IKKε-IRF3 Signalosome and Degrading IRF3 and IKKε.
    Zhang N; Shi H; Yan M; Liu G
    J Immunol; 2021 May; 206(9):2184-2197. PubMed ID: 33858962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.